Michael D. Wortley
Overview
Michael D. Wortley received an average of $3M in total compensation, including $408K in salary, at REATA PHARMACEUTICALS from 2019 to 2021.
Source: SEC filings on April 29, 2022, April 30, 2021, and April 29, 2020.
Related executives
We found six more executives who work or worked at REATA PHARMACEUTICALS.
J Huff
REATA PHARMACEUTICALS
Chief Executive Officer
Manmeet Soni
REATA PHARMACEUTICALS
Chief Financial Officer
Colin Meyer
REATA PHARMACEUTICALS
Chief Innovation Officer and Executive Vice President
Dawn Bir
REATA PHARMACEUTICALS
Chief Commercial Officer and Executive Vice President
Jason Wilson
REATA PHARMACEUTICALS
Executive Vice President, Operations
Keith Ward
REATA PHARMACEUTICALS